The report package Vaccine Markets in Asia to 2022 offers the most up-to-date industry data on the actual market situation, and future outlook for vaccines in different Asian countries.
The package includes country reports from the following countries: Bangladesh, China, India, Indonesia, Israel, Japan, Jordan, Kazakhstan, Lebanon, Malaysia, Nepal, Oman, Pakistan, Philippines, Qatar, Singapore, South Korea, Sri Lanka, Thailand, Vietnam
The research includes historical data from 2011 to 2017 and forecasts until 2022 which makes the reports an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs.
The reports help answer the following questions: - What is the size of the vaccine market in different Asian countries? - How is the market split into different types of vaccines? - How are the overall market and different product types growing? - How is the market predicted to develop in the future?
The latest industry data included in the reports: - Demand for vaccines, 2011-2022 - Vaccine market size by product type, 2011-2022 - Growth rates of the overall market and different product segments, 2011-2022 - Shares of different product segments of the overall market, 2011, 2017, and 2022
The market data is given for the following product segments: Human vaccines Veterinary vaccines
Among the key reasons to purchase include the following: - Gain an outlook of the historical development, current market situation, and future outlook of the vaccine market in different Asian countries to 2022 - Track industry developments and identify market opportunities - Plan and develop marketing, market-entry, market expansion, and other business strategies by identifying the key market opportunities and prospects - Save time and money with the readily accessible key market data included in the reports. The data is clearly presented and can be easily incorporated into presentations and internal reports.
Our reports have been used by over 10K customers, including:
Executive Summary The mRNA technology finds its applications in many diseases including the Covid-19 vaccine. The market for mRNA is mostly driven by the Covid-19 vaccine besides its major usage in cancer therapies. With the mutation of the coronavirus and possible spread of variants of the virus, the mRNA companies are...
This study ’s Healthcare and Life Sciences team provides critical insights into the US COVID-19 vaccines and therapeutics market, including developing vaccines, supply chain considerations, and requirements to manage distribution. The study also identifies actionable and profitable growth opportunities for industry participants.
“Uterine Fibroids - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Uterine Fibroids pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration,...
“Polypoidal choroidal vasculopathy - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Polypoidal choroidal vasculopathy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product...
200 pages •
By The Business Research Company
• Jul 2020
Major players in the COVID19 vaccine and therapeutics clinical trial analysis market are Pfizer, GlaxoSmithKline (GSK), Inovio Pharmaceuticals, Johnson & Johnson (J&J), Novavax Inc., Heat Biologics, Sanofi, BioNTech, Vaxart, and Vir Biotechnology. The urgent need to develop vaccines or therapeutics in response to the outbreak of the...
Tularaemia - Pipeline Review, H1 2020
This latest Pharmaceutical and Healthcare disease pipeline guide Tularaemia – Pipeline Review, H1 2020, provides an overview of the Tularaemia (Infectious Disease) pipeline landscape.
Tularaemia is an infection caused due to a bacterium called...
The Global Veterinary oncology Market size is expected to reach $369.2 Million by 2026, rising at a market growth of 13.2% CAGR during the forecast period. Cancer is one of the main causes of morbidity in veterinary patients and one of the most important surgical procedures undertaken by veterinarians is the surgical removal of tumors. The...
The Asia Pacific Veterinary oncology Market would witness market growth of 14.6% CAGR during the forecast period (2020-2026). Cancers are among the most common diseases that affect dogs. Some of them arise naturally and exhibit certain parallels to human cancers in their physiology and histopathology. There is more, it is seen that...
The Global Tumor Ablation Market size is expected to reach $1.7 billion by 2025, rising at a market growth of 10.9% CAGR during the forecast period. Tumor ablation is a minimally invasive image-guided procedure that is used to treat liver, kidney, soft tissue, and bone tumors. By using heat, chemicals, and low temperature, this procedure ensures...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.